Logo image of GLRE

GREENLIGHT CAPITAL RE LTD-A (GLRE) Stock Fundamental Analysis

NASDAQ:GLRE - Nasdaq - KYG4095J1094 - Common Stock - Currency: USD

13.39  +0.08 (+0.6%)

After market: 13.39 0 (0%)

Fundamental Rating

4

GLRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 144 industry peers in the Insurance industry. Both the profitability and the financial health of GLRE get a neutral evaluation. Nothing too spectacular is happening here. GLRE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

GLRE had positive earnings in the past year.
In the past year GLRE had a positive cash flow from operations.
Of the past 5 years GLRE 4 years were profitable.
In multiple years GLRE reported negative operating cash flow during the last 5 years.
GLRE Yearly Net Income VS EBIT VS OCF VS FCFGLRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M

1.2 Ratios

The Return On Assets of GLRE (4.39%) is better than 74.65% of its industry peers.
GLRE's Return On Equity of 13.24% is in line compared to the rest of the industry. GLRE outperforms 55.63% of its industry peers.
Industry RankSector Rank
ROA 4.39%
ROE 13.24%
ROIC N/A
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A
GLRE Yearly ROA, ROE, ROICGLRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 13.31%, GLRE is in the better half of the industry, outperforming 72.54% of the companies in the same industry.
GLRE's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 9.03%, GLRE perfoms like the industry average, outperforming 48.59% of the companies in the same industry.
In the last couple of years the Operating Margin of GLRE has grown nicely.
Industry RankSector Rank
OM 9.03%
PM (TTM) 13.31%
GM N/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLRE Yearly Profit, Operating, Gross MarginsGLRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

GLRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
GLRE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GLRE has less shares outstanding
GLRE has a better debt/assets ratio than last year.
GLRE Yearly Shares OutstandingGLRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
GLRE Yearly Total Debt VS Total AssetsGLRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of GLRE is 0.60, which is an excellent value as it means it would take GLRE, only 0.60 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.60, GLRE is in the better half of the industry, outperforming 75.35% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that GLRE is not too dependend on debt financing.
GLRE has a better Debt to Equity ratio (0.09) than 80.99% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.6
Altman-Z N/A
ROIC/WACCN/A
WACC8.63%
GLRE Yearly LT Debt VS Equity VS FCFGLRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GLRE Yearly Current Assets VS Current LiabilitesGLRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for GLRE have decreased by -9.68% in the last year.
Measured over the past years, GLRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 151.28% on average per year.
GLRE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.33%.
Measured over the past years, GLRE shows a very strong growth in Revenue. The Revenue has been growing by 30.32% on average per year.
EPS 1Y (TTM)-9.68%
EPS 3Y151.28%
EPS 5YN/A
EPS Q2Q%158.97%
Revenue 1Y (TTM)6.33%
Revenue growth 3Y8.92%
Revenue growth 5Y30.32%
Sales Q2Q%5.1%

3.2 Future

The Earnings Per Share is expected to decrease by -11.82% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-14.29%
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLRE Yearly Revenue VS EstimatesGLRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
GLRE Yearly EPS VS EstimatesGLRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6 -8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.31, the valuation of GLRE can be described as very cheap.
GLRE's Price/Earnings ratio is a bit cheaper when compared to the industry. GLRE is cheaper than 79.58% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.47, GLRE is valued rather cheaply.
GLRE is valuated reasonably with a Price/Forward Earnings ratio of 8.20.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GLRE indicates a somewhat cheap valuation: GLRE is cheaper than 71.83% of the companies listed in the same industry.
GLRE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
Industry RankSector Rank
PE 5.31
Fwd PE 8.2
GLRE Price Earnings VS Forward Price EarningsGLRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

66.90% of the companies in the same industry are more expensive than GLRE, based on the Enterprise Value to EBITDA ratio.
73.24% of the companies in the same industry are more expensive than GLRE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.48
EV/EBITDA 7.96
GLRE Per share dataGLRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

GLRE's earnings are expected to decrease with -11.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GLRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLIGHT CAPITAL RE LTD-A

NASDAQ:GLRE (2/4/2025, 8:00:01 PM)

After market: 13.39 0 (0%)

13.39

+0.08 (+0.6%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners48.58%
Inst Owner Change-1.7%
Ins Owners23.65%
Ins Owner Change0.55%
Market Cap466.37M
Analysts43.33
Price TargetN/A
Short Float %0.73%
Short Ratio2.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.27%
Min EPS beat(2)-9.8%
Max EPS beat(2)52.34%
EPS beat(4)2
Avg EPS beat(4)13.71%
Min EPS beat(4)-9.8%
Max EPS beat(4)52.34%
EPS beat(8)6
Avg EPS beat(8)75.52%
EPS beat(12)6
Avg EPS beat(12)-66.89%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-103.39%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-11.11%
EPS NY rev (3m)5.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.31
Fwd PE 8.2
P/S 0.71
P/FCF 4.48
P/OCF 4.48
P/B 0.7
P/tB 0.7
EV/EBITDA 7.96
EPS(TTM)2.52
EY18.82%
EPS(NY)1.63
Fwd EY12.19%
FCF(TTM)2.99
FCFY22.32%
OCF(TTM)2.99
OCFY22.32%
SpS18.94
BVpS19.05
TBVpS19.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 13.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 9.03%
PM (TTM) 13.31%
GM N/A
FCFM 15.78%
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.6
Debt/EBITDA 1.05
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 10.63
Cash Conversion 174.64%
Profit Quality 118.52%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.68%
EPS 3Y151.28%
EPS 5YN/A
EPS Q2Q%158.97%
EPS Next Y-14.29%
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%
EPS Next 5YN/A
Revenue 1Y (TTM)6.33%
Revenue growth 3Y8.92%
Revenue growth 5Y30.32%
Sales Q2Q%5.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.55%
EBIT growth 3Y98.58%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y260.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y260.31%
OCF growth 3YN/A
OCF growth 5YN/A